ProMIS Neurosciences Filing Effectiveness Noted
Ticker: PMN · Form: EFFECT · Filed: 2026-04-03T00:15:25-04:00
Sentiment: neutral
Topics: filing-effectiveness, sec-filing, pro-mis-neurosciences
TL;DR
ProMIS Neurosciences filing is now SEC effective as of 4/2/2026.
AI Summary
ProMIS Neurosciences Inc. filed an EFFECT form on April 3, 2026, indicating the effectiveness of a filing related to their securities. The filing, with SEC Accession Number 9999999995-26-001071, was accepted at 00:15:25. The effectiveness date is listed as April 2, 2026.
Why It Matters
This filing signifies that a previous submission by ProMIS Neurosciences Inc. has met SEC requirements and is now officially effective, potentially paving the way for further corporate actions or disclosures.
Risk Assessment
Risk Level: low — This is a procedural filing indicating effectiveness, not a filing that inherently introduces new financial or operational risks.
Key Numbers
- 2026-04-02 — Effectiveness Date (The date the filing officially became active with the SEC.)
- 2026-04-03 — Acceptance Date (The date the SEC processed and accepted the filing.)
Key Players & Entities
- ProMIS Neurosciences Inc. (company) — Filer
- 9999999995-26-001071 (dollar_amount) — SEC Accession Number
- 2026-04-03 (dollar_amount) — Acceptance Date
- 2026-04-02 (dollar_amount) — Effectiveness Date
FAQ
What type of filing was made effective?
The filing was an EFFECT form, indicating notice of effectiveness.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 9999999995-26-001071.
When was the filing accepted by the SEC?
The filing was accepted on April 3, 2026, at 00:15:25.
What is the CIK number for ProMIS Neurosciences Inc.?
The CIK number for ProMIS Neurosciences Inc. is 0001374339.
What is the business address of ProMIS Neurosciences Inc.?
The business address is SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2.
From the Filing
EDGAR Filing Documents for 9999999995-26-001071 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001071 Accepted 2026-04-03 00:15:25 Documents 1 Effectiveness Date 2026-04-02 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 595 Complete submission text file 9999999995-26-001071.txt 1833 Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898 ProMIS Neurosciences Inc. (Filer) CIK : 0001374339 (see all company filings) EIN. : 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-294610 | Film No.: 26836699 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)